Chair of the Board
Ms. Dawn Svoronos was elected to the Board of Directors and nominated as Chair of the Board of Theratechnologies in 2013.
Ms. Dawn Svoronos spent 23 years at Merck & Co. Inc. Prior to her retirement in 2011, she was President of the Europe/Canada region from 2009 to 2011 and President for Canada from 2006 to 2009. Previously, she held the positions of Vice President of Asia Pacific and Vice President of Global Marketing for the Arthritis, Analgesics and Osteoporosis franchise.
Ms. Svoronos sits on the Boards of Directors of PTC Therapeutics, Global Blood Therapeutics, Adverum Biotechnologies and Xenon Pharmaceuticals Inc. She also sat on the board of Endocyte and Medivation prior to their respective acquisitions.
Ms. Svoronos received a B.A. in English and French Literature from Carleton University.